Unapproved Peptides Lack Safety Data, Regulatory Incentives Misaligned Matt Kaeberlein posted on the topic LinkedIn The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and RFK Jr. and the Perils of Peptides Washington Monthly FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times BPC 157: Prohibited peptide and unapproved drug in supplements